TTCR

Patricia Fuentes1, Marina García-Peydró1, Juan Alcain1

  • 1Immune System Development and Function Unit. Centro de Biología Molecular Severo Ochoa, Consejo Superior de Investigaciones Científicas (CSIC) and Universidad Autónoma de Madrid (UAM), Madrid, Spain.

Nature immunology
|September 1, 2025
PubMed
概括

针对T细胞前受体 (TCR) 提供了针对T细胞急性淋巴细胞白血病 (T-ALL) 的新免疫疗法. 在临床前模型中,这种方法有效抑制白血病发起细胞和瘤生长.

相关概念视频

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K